Robotimize Group Secures Angel Funding to Enhance Neurorehabilitation

Robotimize Group, a leader in neurorehabilitation robotics, announced the closure of its Angel Round financing, receiving investment from a distinguished private investor committed to healthcare advancements. The funding will bolster research, product innovation, and international expansion, affirming confidence in Robotimize's integration of robotics, AI, and clinical expertise. The capital will focus on R&D, product development, global market expansion, and operational scalability. The company aims to enhance its robotic systems with AI-driven protocols and sensors, validating their efficacy through clinical trials, and expanding into Southeast Asian markets with new subsidiaries in Kuala Lumpur and Jakarta. The funding underlines their mission to provide patient-centered, cost-effective neurorehabilitation solutions, contributing broad societal and economic benefits globally.